Detalles de la búsqueda
1.
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Oncologist
; 28(10): 875-884, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676712
2.
Clinical factors predicting objective response to bevacizumab-based chemotherapies in advanced and recurrent epithelial ovarian cancer.
Minerva Obstet Gynecol
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38837188
3.
Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study.
Medicine (Baltimore)
; 103(9): e37259, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428877
4.
Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer.
Medicine (Baltimore)
; 103(1): e36750, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181291
5.
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.
Medicine (Baltimore)
; 102(45): e35950, 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37960746
6.
Do Not Forget Afghanistan in Times of COVID-19: Telemedicine and the Internet of Things to Strengthen Planetary Health Systems.
OMICS
; 24(6): 311-313, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324451
7.
Immunohistochemical expression of plasminogen activator inhibitor-1 in subcutaneous versus omental adipose tissue in patients after elective abdominal surgery.
Autops Case Rep
; 9(4): e2019121, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641662
8.
Immunohistochemical expression of plasminogen activator inhibitor-1 in subcutaneous versus omental adipose tissue in patients after elective abdominal surgery
Autops. Case Rep
; 9(4): e2019121, Oct.-Dec. 2019. ilus, tab
Artículo
en Inglés
| LILACS | ID: biblio-1024063
Resultados
1 -
8
de 8
1
Próxima >
>>